Patents Represented by Attorney John S. Roberts, Jr.
  • Patent number: 4308149
    Abstract: Oily waste emulsions which cause low turbidity in industrial waste water effluents are successfully treated with cross-linked cationic polymeric compounds synthesized by reacting phenol, substituted phenol, formaldehyde and various low molecular weight polyamines having a preferred molecular weight of at least 1500 and not exceeding a molecular weight of about 30,000. The polyamines are derived from a base catalyzed polymerization of ammonia and ethylene dichloride or by the oligomerization of ethyleneimine.
    Type: Grant
    Filed: July 14, 1980
    Date of Patent: December 29, 1981
    Assignee: Nalco Chemical Company
    Inventor: R. Selvarajan
  • Patent number: 4307215
    Abstract: A method of using formic acid or metal salts thereof in effective concentrations as very efficient chain transfer agents to limit the molecular weight and intrinsic viscosity of acrylamide based polymers. The formic acid or metal formate is utilized in such polymers by adding to the monomer prior to polymerization amounts of 0.05-6.5% by weight to control polymer molecular weights where the subsequent polymer is to be used as a flocculating agent, sewage treatment agent, or any other appropriate use. Polymers of special interest in this invention are polyacrylamide and anionic or cationic copolymers of acrylamide. Examples of polymers which can be made according to this invention include polyacrylamide (nonionic), copolymers of acrylamide, and N,N-dimethylaminoethylmethacrylate (cationic) and copolymers of acrylamide and acrylic acid (anionic). In the manufacture of the subject polymer, the percent monomer employed can range from about 10-90% by weight and is preferably from 10-50% by weight.
    Type: Grant
    Filed: February 25, 1980
    Date of Patent: December 22, 1981
    Assignee: Nalco Chemical Company
    Inventors: Louis A. Goretta, Robert R. Otremba
  • Patent number: 4306983
    Abstract: A method of preparing overbased or superbased magnesium sulfonates by sulfonating an alkyl benzene with a material containing SO.sub.3, preferably oleum, and reacting the alkyl benzene sulfonate with magnesium oxide in the presence of a low viscosity diluent, such as No. 2 oil or LOPS (low odor paraffin solvent), together with water, alcohol, and CO.sub.2. The newness of the method lies in the steps of preferably positively utilizing oleum which contains a minor amount of sulfuric acid as a promoter and utilizing also a surfactant couple of a C.sub.12 -C.sub.18 fatty acid such as oleic acid and an ethanol amide such as a lauryl diethanol amide, which may be Witcamide 5138; where a ready made sulfonate is used, such as SA697 (Conoco), H.sub.2 SO.sub.4 is utilized. In certain instances the amide may be omitted with satisfactory results occurring by using the acid alone.
    Type: Grant
    Filed: September 4, 1980
    Date of Patent: December 22, 1981
    Assignee: Nalco Chemical Company
    Inventors: Ronald J. Allain, Dodd W. Fong
  • Patent number: 4306064
    Abstract: In a method of preparing methotrexate from a coupling of 2,4-bis(triphenylphosphazino)-6-bromomethylpteridine hydrobromide with ethyl N-(p-methylamino)-benzoyl-L-glutamate to produce the phosphazino derivative of methotrexate ester and subsequently hydrolyzing the phosphazino and ester groups to produce the free methotrexate, the pteridine synthesis step wherein molecular oxygen is substituted for reaction air and the pH throughout the pteridine synthesis is regulated to between 2.5 and 5.4, the preferred pH being about 3.0 and producing from tetraaminopyrimidine and dihydroxyacetone the isomer 2,4-diamino-6-hydroxymethylpteridine over 2,4-diamino-7-hydroxymethylpteridine in a ratio of about 20:1. Exemplary of other situations involving pteridine where the molecular oxygen may be substituted for reaction air are: in the production of folic acid, tetrahydrofolic acid, etc.
    Type: Grant
    Filed: March 25, 1980
    Date of Patent: December 15, 1981
    Inventors: James A. Ellard, Joseph Satanek, Jr.
  • Patent number: 4306071
    Abstract: 1,4-Bis(2'-haloethyl)-1,4-diazabicyclo[2.2.1]-heptane derivatives, such as diperchlorate, dichloride, diacetate, dibenzoate, diascorbate, disalicylate, ditartrate, disaccharin, dihydrogen dimaleate, together with ethyl sulfonate and periodate.
    Type: Grant
    Filed: November 14, 1979
    Date of Patent: December 15, 1981
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: George R. Pettit, Donald P. Gieschen, William E. Pettit
  • Patent number: 4303438
    Abstract: The present invention relates to a method for improving a soil structure by stabilization of aggregates. According to the invention it is applied to the soil a graft polymer substantially free of monomer, having an intrinsic viscosity below 1 dg/l and a molecular weight below 100,000. The graft polymer is obtained by the exothermic reaction of a water soluble lignosulfonate with a member selected from the group consisting of acrylic acid, methacrylic acid and mixtures thereof. The graft polymers have been found to be also useful as binding reagents for agglomerating single particles of particulate materials.The graft polymers according to the invention are obtained in the form of an aqueous solution, which may be transformed into a powder by spray drying. As soil conditioners they may be applied by spraying, alone or admixed with fertilizers or pesticides and also combined with the operation of planting and soil stabilization.
    Type: Grant
    Filed: October 23, 1978
    Date of Patent: December 1, 1981
    Assignee: Technion Research & Development Foundation, Ltd.
    Inventors: Dan Zaslavsky, Lev V. Rozenberg
  • Patent number: 4300557
    Abstract: An improved process for dispensing a lipid soluble labile drug, i.e. 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) by diffusion through a silicone capsule implanted at a periocular site to an intraocular site within an animal body being treated with the drug, the improvements wherein the silicone capsule is provided with a tube sealed at the distal end thereof and provided with longitudinal slit cut through the tube wall inside the capsule for filling the capsule following implantation of the capsule, wherein the capsule is implanted surgically near the site being treated so that the tube is accessible for filling without further surgical procedures and wherein the drug is injected into the capsule through the tube in the form of a solution in a solvent which is non-toxic to the animal being treated, inert with respect to the drug dissolved therein and capable of diffusing from the capsule within 5 hours to leave a residue of the drug in the capsule.
    Type: Grant
    Filed: January 7, 1980
    Date of Patent: November 17, 1981
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Miguel F. Refojo, Hsaio S. Liu
  • Patent number: 4298233
    Abstract: The invention relates to a milling tool for a rotating milling cylinder with milling head possibly equipped with hard metal, for milling away bonded mineral materials, having a stop part and retaining part for insertion into the radially outwardly open tool holder arranged on the milling cylinder circumference, in which holder the tool is arrestable by means of push-in bolts, while the retaining and stop part insertable into the tool holder is provided on each of its two ends with a milling head the maximum cross-sectional dimensions of which are such that they do not protrude beyond the cross-sectional area of the retaining and stop part, and the stop part finds its abutment in the tool holder.
    Type: Grant
    Filed: June 7, 1979
    Date of Patent: November 3, 1981
    Inventor: Gerd Elfgen
  • Patent number: 4289882
    Abstract: This invention relates to the production of 4a-aryldecahydroisoquinolines where the aryl group is selected as 3-methoxy phenyl and intermediates. These compounds are morphine analogs and show utility similar to the known morphine, codeine, and thebaine.
    Type: Grant
    Filed: September 5, 1978
    Date of Patent: September 15, 1981
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventors: Henry Rapoport, Dwight D. Weller, Richard D. Gless
  • Patent number: 4284579
    Abstract: In binary treatment with cis-dichlorodiamine-platinum(II) (or cisplatin) the preferred ratio of the present compound to cisplatin is about 10:1 with a range of about 10:1 to 1:10 in mg/kg of body weight.As to the variations in the formula on the left hand side of the formula, it may be varied as monodentate, such as cisplatin containing a single amine group proceeding from the ring, or bidentate, such as the present compound. The saturated cyclo ring may be C.sub.4 or C.sub.5 -C.sub.7 in addition to the present cyclohexane.The present platinum compound may be prepared by reacting the known L-aspartic acid, N-(phosphonacetyl-) disodium salt (PALA; NSC-224131), with dinitrato(1,2-diaminocyclohexane)platinum(II) (NSC-239851). This compound N-phosphonacetyl-L-aspartato(1,2-diaminocyclohexane)platinum(II) may be combined in multiple drug regimen with substantially improved yield cures over the parent compounds.
    Type: Grant
    Filed: June 9, 1980
    Date of Patent: August 18, 1981
    Assignee: The United States of America as represented by the of the Department of Health & Human Services
    Inventors: Sandra J. Meischen, Glen R. Gale, Marion B. Naff
  • Patent number: 4284537
    Abstract: Certain peptide fragments of streptococcal M protein named CB6 and CB7 have been linked to a protein carrier which is polylysine. The conjugate has proved immunogenic in rabbits producing protective antibodies against the whole group A streptococcus.
    Type: Grant
    Filed: July 3, 1980
    Date of Patent: August 18, 1981
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventor: Edwin H. Beachey
  • Patent number: 4283391
    Abstract: A new antibiotic named pamamycin is derived from S. alboniger. The antibiotic compound is neutral and terpene-like as derived from S. alboniger. The antibiotic is produced in conjunction with substances which either stimulate or inhibit the transition of substrate to aerial mycelia. Pamamycin may be separated by thin layer chromatography. The antibiotic displays particular R.sub.f values in thin layer chromatography as well as a particular antimicrobial spectrum for its use. The molecular formula is 621 and the elemental formula thereof is C.sub.36 H.sub.63 NO.sub.7 as determined by mass spectroscopy. The structure is believed to be a saturated alkane and terpene-like. In vivo tests with Staphylococcus aureus indicate that pamamycin is a potent inhibitor of both DNA and RNA synthesis and this antibiotic has present utility in a 1% solution to degerminate hospital walls.
    Type: Grant
    Filed: July 16, 1979
    Date of Patent: August 11, 1981
    Assignee: St. Louis, University
    Inventors: Burton M. Pogell, Pamela A. McCann
  • Patent number: 4279898
    Abstract: Dialkyl esters of 5-carbo[etiocholane-3'.alpha.-7'.alpha., 12'.alpha.-trihydroxy-17'.beta.(1" methyl-4' butyl]oxy-4-hydroxy-4-methylpentyl-1-phosphonate and 5-carbohexadecyloxy-4-hydroxy-4-methylpentyl-1-phosphonate are shown to inhibit cholesterol biosynthesis in rat liver cells. Preparation of the active compounds is given.
    Type: Grant
    Filed: April 22, 1980
    Date of Patent: July 21, 1981
    Assignee: Research Foundation of the City University of New York
    Inventors: Robert R. Engel, Virender K. Sarin, Barry Gotlinksy, Burton E. Tropp, Thomas S. Parker
  • Patent number: 4279817
    Abstract: A concerted process for the synthesis of a dimer consisting of an indole unit and a dihydroindole unit possessing natural stereochemistry which comprises:(a) forming an N-oxide intermediate from said indole unit;(b) treating said N-oxide indole intermediate in the presence of acetic anhydride or halogenated derivative thereof to effect a Polonovski-type fragmentation reaction;(c) without isolating the N-oxide indole intermediate and at a temperature of about -10.degree. C. to +10.degree. C., coupling said reaction product with a dihydroindole unit in the presence of acetic anhydride or a halogenated derivative thereof at a low temperature of about -10.degree. C. to +10.degree. C. under inert conditions; and(d) subsequently reducing the immonium nitrogen on the indole unit by reacting with aqueous alkali metal borohydride to produce a dimer.
    Type: Grant
    Filed: May 30, 1975
    Date of Patent: July 21, 1981
    Assignee: The United States of America as represented by the Department of Health & Human Services
    Inventor: James P. Kutney
  • Patent number: 4277604
    Abstract: Thebaine is converted to a mixture of codeinone and neopinone in aqueous formic acid solution containing as catalyst a mercuric salt. Thebaine is converted to a neopinone ketal by irradiation in an alkanol or to a mixture of neopinone and codeinone in an acidic aqueous solution. Neopinone ketals, codeinone and neopinone can be converted to codeine.
    Type: Grant
    Filed: January 25, 1980
    Date of Patent: July 7, 1981
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: William G. Dauben, Craig P. Baskin, Herman C. H. A. vanRiel
  • Patent number: 4277292
    Abstract: A highly acidic aqueous conversion coating for aluminum which is corrosion resistant, provides excellent adhesion with overlaying coatings and does not blacken when the coating substrate is immersed in boiling water. The coating composition is a ternary variety which contains zirconium, fluoride, and tannin. The pH of the coating bath is uniquely more acidic than conventional baths which operate at a pH of 3 and above, and is between 2.3 and 2.95.
    Type: Grant
    Filed: March 26, 1980
    Date of Patent: July 7, 1981
    Assignee: Coral Chemical Company
    Inventor: George L. Tupper
  • Patent number: 4275057
    Abstract: Seven-membered heterocyclic nucleosides used to inhibit the deamination enzyme responsible for the inactivation of arabinosylcytosine (ara--C). Preferred nucleosides containing a seven-member aglycone are as follows: ##STR1## Preferred aglycones are as follows: ##STR2## Active components utilized against pyrimidine deaminases from mammalian tissues (mouse kidney and human liver) showed optimum advantage when compared with tetrahydrouridine (THU).
    Type: Grant
    Filed: January 28, 1980
    Date of Patent: June 23, 1981
    Assignee: The United States of America as represented by the Department of Health, Education and Welfare
    Inventors: Victor E. Marquez, Paul S. Liu, John S. Driscoll
  • Patent number: 4268352
    Abstract: This invention is a method of increasing the amount of retention of deposited starch and pigment on fibers in broke liquid which consists of adding to said liquid a combination dosage of a DMA-epichlorohydrin polymer together with a second polymer consisting of acrylamide/acrylate. Such a polymer may be anionic, such as an acrylamide/sodium acrylate 5% or 30% acrylic acid, or it may be cationic, such as acrylamide/dimethylamino ethyl methacrylate dimethyl sulfate quaternary. The polymers may be applied to the broke directly and preferably in the form of an inverted water-in-oil emulsion. The dosage based on dry weight of starch (T) ranges from 2-35 lbs/T of the DMA-epichlorohydrin polymer product (48% polymer, 0.96-16.8 lbs/T polymer) and 0.5-8 lbs/T based on the second polymer product (28% polymer, 0.14-2.24 lbs/T polymer) selected from the group consisting of copolymers of acrylamide/acrylic acid; copolymers of acrylamide/alkali metal acrylate (e.g.
    Type: Grant
    Filed: May 30, 1979
    Date of Patent: May 19, 1981
    Assignee: Nalco Chemical Company
    Inventors: David R. Cosper, Patricia R. Soll
  • Patent number: 4266139
    Abstract: A shielding means for an x-ray machine comprised of a base plate which removably receives overlays masking out selective portions of the base plate to control the passage of the x-rays therethrough. The overlays are generally identical and provided with co-operating removable securing means to permit the same to be stacked one on the other to vary the thickness thereof. Removable mounting rails position and maintain the shielding means on the x-ray machine.
    Type: Grant
    Filed: January 7, 1980
    Date of Patent: May 5, 1981
    Inventors: Louis Sportelli, James F. Winterstein
  • Patent number: 4256646
    Abstract: In an elegant stepwise process for the production of intermediates of thromboxanes such as TXB.sub.2 from a chiral glucose starting material such as .alpha.-methylglucoside, those steps comprising: ##STR1## A key modification introduced in this synthetic sequence is the use of 4-dimethylaminopyridine for the selective alkylation of primary alcohols in the presence of unprotected secondary alcohols and for the controlled acylation of methylglucoside. The former application has large potential use in the synthesis of nucleosides, polynucleotides, and carbohydrate derivatives.
    Type: Grant
    Filed: April 16, 1979
    Date of Patent: March 17, 1981
    Assignee: The United States of America as represented by the Department of Health, Education and Welfare
    Inventors: Oscar Hernandez, John R. Bend, Thomas E. Eling, James D. McKinney